Detox Drug Could Be Available in U.S. Soon
By 2005, Britannia Pharmaceuticals Ltd. of Great Britain could have its drug lofexidine available in the U.S. to help detoxify individuals addicted to heroin and other opiates, the Wall Street Journal reported Nov. 18.
Currently, lofexidine is used in Britain to treat withdrawal symptoms such as vomiting and diarrhea.
Britannia Pharmaceuticals has licensed U.S. rights for the drug to US WorldMeds LLC in Louisville, Ky.
"We are hoping that the success in the U.K. will be replicated in the U.S.," said Max Noble, Britannia Pharmaceuticals' managing director.
A large trial of the drug is expected to begin next year, according to P. Breckinridge Jones, chief executive of US WorldMeds. The company hopes to receive U.S. Food and Drug Administration approval to market the drug by the end of 2005.
Source: www.jointogether.org
Heroin Detox • Oxycontin Drug Addiction • Drug Rehab Program • Rehab Programs • Oxycontin Diversion and Abuse • Sober Living Prescription Drug Abuse Help • Alcohol Treatment • Oxycontin Abuse Treatment • Alcohol Treatment CentersTexas Drug Rehabs • Alcohol Addictions • Rehabilitation Centers • Residential Treatment Programs • Drugs and Alcohol Addiction Help |
||
|
||
The information provided on the Heroin Detox web site is for informational purposes only and should not be treated as medical, psychiatric, psychological or behavioral health care advice. Nothing contained on the Heroin Detox web site is intended to be used for medical diagnosis or treatment or as a substitute for consultation with a qualified health care professional. Heroin Detox contains advertisements and links to third party websites. Heroin Detox does not make any representation, warranty, or endorsement of any product or service or the content or accuracy of any materials contained in, or linked to, any advertisement or link on the Site |
||
| Call Us Toll Free at 888.471.0430 for Help © 2001-2007 Heroin Detox |
